CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

PLXProtalix BioTherapeutics, Inc.

AMEX · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $2.76 · 2026-09-30
ABOUT
ExchangeAMEX
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$222.38M
CountryUSA
RECENT INSIDER TRADES
  • 2025-12-23 · Bashan Dror (PRESIDENT AND CEO) · BUY
  • 2025-11-19 · Bar-Shalev Amos (Director) · SELL
  • 2025-08-12 · Schwartz Aharon (Director) · BUY
INSTITUTIONAL OWNERSHIP
Institutional holders106
Shares held15,365,168
Value$34.96M
Percent of shares outstanding19.07%
As of quarter end2026-06-30
RECENT NEWS
  • Protalix BioTherapeutics presents at Morgan Stanley healthcare conference
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Protalix BioTherapeutics, Inc. (PLX) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit